Trial intelligence / Profile preview

Thiotepa and Radiotherapy in Pediatric High-Grade Astrocytic Tumors

NCT00313521Phase 2Unknown

Sponsor
Children's Cancer and Leukaemia Group
Start
Jun 1995
Primary completion
Nov 1997
Modality
Small Molecules
01

Overview

Phase 2, open-label, single-arm trial of thiotepa in astrocytoma, sponsored by Children's Cancer and Leukaemia Group. Primary endpoints: Tumor response to adjuvant thiotepa followed by radiotherapy and Degree of surgical resection. Status: unknown.

02

Drugs

thiotepa
03

Conditions

astrocytoma

Beyond the preview

Go deeper on NCT00313521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00313521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call